Form 4: VolitionRx CEO Receives Stock Award in Lieu of Cash Compensation
SEC Form 4 Filing
Jasmine Kway, CEO of VolitionRx Singapore, received 16,708 restricted stock units (RSUs) in lieu of cash compensation on March 1, 2025.
Summary
- Jasmine Kway, CEO of VolitionRx Singapore, filed a Form 4 on March 4, 2025, reporting changes in beneficial ownership.
- On March 1, 2025, Kway was awarded 16,708 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation.
- The RSUs vest in three installments on March 1, 2025, April 1, 2025, and May 1, 2025, and are subject to further time-based vesting on March 1, 2026, contingent upon continued service.
- Following the transaction, Kway directly owns 182,780 shares of common stock and indirectly owns 10,400 shares through a spouse.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to slightly positive.
Positives
- The award of RSUs aligns the CEO's interests with those of the shareholders.
- The vesting schedule incentivizes continued service and commitment to the company.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The RSU award could be viewed positively by shareholders as it aligns management's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Date of RSU award and first vesting installment (5,570 units) |
| 04/01/2025 | Second vesting installment (5,569 units) |
| 05/01/2025 | Third vesting installment (5,569 units) |
| 03/01/2026 | Final vesting installment, subject to continued service |
| 03/04/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.